{"schemaVersion":"peptidescanner-peptide-evidence-feed/v1","canonicalUrl":"https://peptidescanner.com/feeds/peptides/goserelin.json","peptide":{"slug":"goserelin","name":"Goserelin","url":"https://peptidescanner.com/peptides/goserelin/"},"release":{"label":"Beta · 17 Nov 2026","reviewedAt":"2026-11-17"},"entryCount":64,"entries":[{"objectId":"story:clinicaltrials-gov-nct00004124-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00004124","domain":"Clinical trials","dateInSource":"2022-12-30","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00004124-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00004124-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct00004124-goserelin-v1","contentSha256":"2df134481b5995d7829852c66abafcef238c2fb63eca7a270f580db421527294"},{"objectId":"story:clinicaltrials-gov-nct00005044-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00005044","domain":"Clinical trials","dateInSource":"2022-06-15","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00005044-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00005044-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct00005044-goserelin-v1","contentSha256":"6d435fccad8634c93d13a7ed1abd1fe76606a0ae0d01b34a03ce536c234e88d5"},{"objectId":"story:clinicaltrials-gov-nct00108732-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00108732","domain":"Clinical trials","dateInSource":"2015-06-30","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00108732-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00108732-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct00108732-goserelin-v1","contentSha256":"9a22ba2bade85179efba33e4cf5e66ff69c973dee442fbcf916f231e9a7e62dd"},{"objectId":"story:clinicaltrials-gov-nct00114114-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00114114","domain":"Clinical trials","dateInSource":"2019-10-08","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00114114-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00114114-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct00114114-goserelin-v1","contentSha256":"dd30d233796ce108c6d98265010fc0e6addd7ee957260740e93d3f95fcc9aba2"},{"objectId":"story:clinicaltrials-gov-nct00186121-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00186121","domain":"Clinical trials","dateInSource":"2019-10-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00186121-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00186121-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct00186121-goserelin-v1","contentSha256":"4b7e9cf1b523d15035f33fafda0c88536ee005c00b3b630162012b0619812c9a"},{"objectId":"story:clinicaltrials-gov-nct00283803-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00283803","domain":"Clinical trials","dateInSource":"2018-08-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00283803-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00283803-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct00283803-goserelin-v1","contentSha256":"e829bf72951ae71919e4c922a70cd95db26a27ccb886e7ca1ca23fe3b37d5c29"},{"objectId":"story:clinicaltrials-gov-nct00295646-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00295646","domain":"Clinical trials","dateInSource":"2024-03-15","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00295646-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00295646-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct00295646-goserelin-v1","contentSha256":"c2c4355069e7e7cf89720d59f95e3ef36495981926587a3a85f553580612d1a7"},{"objectId":"story:clinicaltrials-gov-nct00322348-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00322348","domain":"Clinical trials","dateInSource":"2011-01-24","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00322348-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00322348-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct00322348-goserelin-v1","contentSha256":"f149d733b96fd37d43b1d6c19d4e8a36aedf0eee9fab5f1339eab481af53d52f"},{"objectId":"story:clinicaltrials-gov-nct00328614-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00328614","domain":"Clinical trials","dateInSource":"2025-05-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00328614-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00328614-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct00328614-goserelin-v1","contentSha256":"e245c7060634a89fed92896af6a2a2f5e48a0d827c442a47e8100b8ea9b68045"},{"objectId":"story:clinicaltrials-gov-nct00432172-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00432172","domain":"Clinical trials","dateInSource":"2023-04-03","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00432172-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00432172-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct00432172-goserelin-v1","contentSha256":"8659fc65eff18c0dd8e86ea2b536af2ec776ef4022622eb191f81ba41ac04ea8"},{"objectId":"story:clinicaltrials-gov-nct00586898-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00586898","domain":"Clinical trials","dateInSource":"2016-03-25","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00586898-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00586898-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct00586898-goserelin-v1","contentSha256":"d9267fc61cb3cb74c4f89d4d1739c43a3d01e36efd8ecaad801215643d1da94f"},{"objectId":"story:clinicaltrials-gov-nct00605267-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00605267","domain":"Clinical trials","dateInSource":"2012-09-06","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00605267-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00605267-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct00605267-goserelin-v1","contentSha256":"f713ffbdf1a1dc3d9bbc32b338dc258fb95db69c26268801e3b1d3ba246660ac"},{"objectId":"story:clinicaltrials-gov-nct01073865-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01073865","domain":"Clinical trials","dateInSource":"2018-12-12","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01073865-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct01073865-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct01073865-goserelin-v1","contentSha256":"038087a9923b7ca59378b37c97ed9ad0d46b218f0644a816fb018c46ba93cdf6"},{"objectId":"story:clinicaltrials-gov-nct01250717-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01250717","domain":"Clinical trials","dateInSource":"2014-02-04","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01250717-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct01250717-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct01250717-goserelin-v1","contentSha256":"a1b6334df9c708d6729b63390864f88eede348ca44a7b534a2ddbc0585cf2552"},{"objectId":"story:clinicaltrials-gov-nct01496131-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01496131","domain":"Clinical trials","dateInSource":"2018-03-09","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01496131-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct01496131-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct01496131-goserelin-v1","contentSha256":"7c8cfc681706a38120032d23251aa35eb70c63bc78fe42ccee488d9dd97198c1"},{"objectId":"story:clinicaltrials-gov-nct01682642-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01682642","domain":"Clinical trials","dateInSource":"2015-03-20","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01682642-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct01682642-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct01682642-goserelin-v1","contentSha256":"5b9f72852962e35e9a34bd23bde17ed54c45fff66a2b50e855802386d9413e1a"},{"objectId":"story:clinicaltrials-gov-nct01723774-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01723774","domain":"Clinical trials","dateInSource":"2026-09-25","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01723774-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct01723774-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct01723774-goserelin-v1","contentSha256":"05b1ed9106b6b383078454fbf15bfe0bb05029a6ee85f86b590a9d154f9cd076"},{"objectId":"story:clinicaltrials-gov-nct02003209-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02003209","domain":"Clinical trials","dateInSource":"2026-10-06","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02003209-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct02003209-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct02003209-goserelin-v1","contentSha256":"af477fcc1bb257159332325244f6241550ab29ad7fad54ed9c0f047a37886433"},{"objectId":"story:clinicaltrials-gov-nct02115282-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02115282","domain":"Clinical trials","dateInSource":"2026-10-22","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02115282-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct02115282-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct02115282-goserelin-v1","contentSha256":"6193c5f8567a323f6442e37d725988d60fe9392e99178fef1263bfba19deb3e7"},{"objectId":"story:clinicaltrials-gov-nct02278120-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02278120","domain":"Clinical trials","dateInSource":"2024-03-12","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02278120-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct02278120-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct02278120-goserelin-v1","contentSha256":"5c2995641025665369c6f313e6492b1aba0a7006f2137a4f8675f7b112c55510"},{"objectId":"story:clinicaltrials-gov-nct02430480-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02430480","domain":"Clinical trials","dateInSource":"2025-07-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02430480-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct02430480-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct02430480-goserelin-v1","contentSha256":"bf18d793940e866412c6ac6b6ca033b7156994891e1565df13286c001ad3e560"},{"objectId":"story:clinicaltrials-gov-nct02518191-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02518191","domain":"Clinical trials","dateInSource":"2021-06-11","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02518191-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct02518191-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct02518191-goserelin-v1","contentSha256":"3b21d74613b92c137272f2542e7bd31dc61c76b2c9311f7127690415db5f6cc4"},{"objectId":"story:clinicaltrials-gov-nct02586675-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02586675","domain":"Clinical trials","dateInSource":"2022-01-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02586675-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct02586675-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct02586675-goserelin-v1","contentSha256":"beeadb6496d89335c057dce2227f7c59e94aabf41d8be9ed4d08a0ce99774ed9"},{"objectId":"story:clinicaltrials-gov-nct03007979-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT03007979","domain":"Clinical trials","dateInSource":"2024-03-20","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03007979-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct03007979-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct03007979-goserelin-v1","contentSha256":"d3f48533dc61cadec1ef208870afe101f3f034e7104e1f3821a687ab3702e3af"},{"objectId":"story:clinicaltrials-gov-nct03096847-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT03096847","domain":"Clinical trials","dateInSource":"2021-10-11","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03096847-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct03096847-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct03096847-goserelin-v1","contentSha256":"1acfe8fc6f15189cef02a4a81913cc9203a2a8e9bcad74b04f4581c80d25ca2d"},{"objectId":"story:clinicaltrials-gov-nct03671330-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT03671330","domain":"Clinical trials","dateInSource":"2026-07-08","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03671330-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct03671330-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct03671330-goserelin-v1","contentSha256":"f8a38594ff116eca5a6fc60451752e7109d9b5d9d7a34069c52fd8b2ba94cb32"},{"objectId":"story:clinicaltrials-gov-nct03822468-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT03822468","domain":"Clinical trials","dateInSource":"2025-10-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03822468-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct03822468-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct03822468-goserelin-v1","contentSha256":"d2fd21aee2e16fde0d7431335dd5460eb0dd7cbc81ffa3c83e16e4766fbfce6d"},{"objectId":"story:clinicaltrials-gov-nct03839823-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT03839823","domain":"Clinical trials","dateInSource":"2024-10-09","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03839823-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct03839823-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct03839823-goserelin-v1","contentSha256":"49bd38aed64ff83abed6530af194a749c87549ba92ef0380b27349f2f8448d4a"},{"objectId":"story:clinicaltrials-gov-nct05161195-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT05161195","domain":"Clinical trials","dateInSource":"2026-10-19","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05161195-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct05161195-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct05161195-goserelin-v1","contentSha256":"6874ba617aa32637a5354bbc844b7474f5f9176ddfe1f0c88fe36fadf6cf686a"},{"objectId":"story:clinicaltrials-gov-nct07310420-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT07310420","domain":"Clinical trials","dateInSource":"2026-11-12","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07310420-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct07310420-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#clinicaltrials-gov-nct07310420-goserelin-v1","contentSha256":"f308072cb3fa26cc3167fc318de62a40e01f29e15e3e54d409a63f1ff408d5dc"},{"objectId":"story:fda-drugs-nda019726:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application NDA019726","domain":"Regulatory","dateInSource":"1989-12-29","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-nda019726/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#fda-drugs-nda019726-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#fda-drugs-nda019726-v1","contentSha256":"938cb4780ccdccd901de2a108b9dd22d55458da94eee515fb4618af9a3e1dd4a"},{"objectId":"story:fda-drugs-nda020578:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application NDA020578","domain":"Regulatory","dateInSource":"1996-01-11","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-nda020578/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#fda-drugs-nda020578-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#fda-drugs-nda020578-v1","contentSha256":"58925c43348e85e8ddce5db2a69c8614eafdb2578decec5ef4ba76779d141e97"},{"objectId":"story:federal-register-2022-25210:v1","state":"current","stateChangedAt":"2026-11-15","title":"Federal Register notice 2022-25210","domain":"Regulatory","dateInSource":"2022-11-18","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/federal-register-2022-25210/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/calcitonin-salmon.json#federal-register-2022-25210-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/calcitonin-salmon.md#federal-register-2022-25210-v1","contentSha256":"5cf189da27f49f0870c97f2370a3d15c25fc8e61f954e5da798573b7c065b9de"},{"objectId":"story:federal-register-97-10911:v1","state":"current","stateChangedAt":"2026-11-15","title":"Federal Register notice 97-10911","domain":"Regulatory","dateInSource":"1997-04-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/federal-register-97-10911/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#federal-register-97-10911-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#federal-register-97-10911-v1","contentSha256":"0b307b7906ac6171b1369b1147378121c72f4141865491afda14ba206dbb9a4c"},{"objectId":"story:pubmed-pmid-12183859-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Treating relapsed epithelial ovarian cancer with luteinizing hormone-releasing agonist (goserelin) after failure of chemotherapy.","domain":"Literature metadata","dateInSource":"2013-11-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-12183859-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-12183859-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-12183859-goserelin-v1","contentSha256":"e1ca300dbecf33fd6f4fb499ea7b9720b2c027883dc18b0a0b8b324efadf4548"},{"objectId":"story:pubmed-pmid-12217302-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Adjuvant endocrine treatment (goserelin vs tamoxifen) in pre-menopausal patients with operable node positive stage II breast cancer. A prospective randomized national multicenter study.","domain":"Literature metadata","dateInSource":"2019-11-06","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-12217302-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-12217302-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-12217302-goserelin-v1","contentSha256":"5d0101c2147e85873dcd5ab6e4ddd871fdc539dfa0c57b2f5e79658a49c3bc2d"},{"objectId":"story:pubmed-pmid-12477997-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Goserelin acetate as treatment for recurrent endometrial carcinoma: a Gynecologic Oncology Group study.","domain":"Literature metadata","dateInSource":"2019-09-06","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-12477997-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-12477997-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-12477997-goserelin-v1","contentSha256":"5c7886973fcc6a416ea3117cc669ff0400a7444ca8e5d1fce0e1ca8f46b95647"},{"objectId":"story:pubmed-pmid-12488405-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patien…","domain":"Literature metadata","dateInSource":"2016-11-02","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-12488405-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-12488405-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-12488405-goserelin-v1","contentSha256":"c06077872c3558616ccc1ac45f0a767a32ffd63bc3d2694cc36e63aaf96bcd94"},{"objectId":"story:pubmed-pmid-14530912-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF).","domain":"Literature metadata","dateInSource":"2018-11-13","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-14530912-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-14530912-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-14530912-goserelin-v1","contentSha256":"41d765d411a0a20e4a9f9cf18c5ae39ba61240d752b1d99bc5b3ebdedc8376f0"},{"objectId":"story:pubmed-pmid-14679153-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.","domain":"Literature metadata","dateInSource":"2022-03-31","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-14679153-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-14679153-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-14679153-goserelin-v1","contentSha256":"cbecf5a946eb149da997ab1d2fa7343388388097b61ad850a7fe81b059e49770"},{"objectId":"story:pubmed-pmid-14760369-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer.","domain":"Literature metadata","dateInSource":"2022-03-09","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-14760369-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-14760369-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-14760369-goserelin-v1","contentSha256":"0b7c06a89fead5c6ffe47ead0fd80e0844104e728d4ddbbcc862e7864ebc447b"},{"objectId":"story:pubmed-pmid-15590321-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Goserelin ('Zoladex')--offering patients more choice in early breast cancer.","domain":"Literature metadata","dateInSource":"2026-01-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15590321-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-15590321-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-15590321-goserelin-v1","contentSha256":"935d8f30823affb541b5bb0d04e6938cc4baf50f841a5df7ecd8fada576d534f"},{"objectId":"story:pubmed-pmid-15592276-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"European randomized, multicenter study of goserelin (Zoladex) in the management of mastalgia.","domain":"Literature metadata","dateInSource":"2013-11-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15592276-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-15592276-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-15592276-goserelin-v1","contentSha256":"a05cd202966875ec3fc0144e658d15cc54b737c42478aa0763521370df767118"},{"objectId":"story:pubmed-pmid-15668708-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer.","domain":"Literature metadata","dateInSource":"2024-08-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15668708-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-15668708-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-15668708-goserelin-v1","contentSha256":"b475f1ab6405f2792497bee22f507880f5a4474f7d1b0e204295cf4facc719d7"},{"objectId":"story:pubmed-pmid-16111461-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Use of goserelin in the treatment of breast cancer.","domain":"Literature metadata","dateInSource":"2013-11-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-16111461-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-16111461-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-16111461-goserelin-v1","contentSha256":"278f308cef3f3883cc131602c8cdcb4b1ec73dfae1fb82ffab8d16cb1f82ece1"},{"objectId":"story:pubmed-pmid-16222310-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer.","domain":"Literature metadata","dateInSource":"2022-03-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-16222310-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-16222310-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-16222310-goserelin-v1","contentSha256":"fc1aa6071e08985ab2dc8ed445efbc7bd894fa779bf281f5ab59fb3757eabc1d"},{"objectId":"story:pubmed-pmid-16352931-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"[Assessment of goserelin treatment in adjuvant therapy for premenopausal patients with breast cancer in Japan-zoladex breast cancer study group trial-B].","domain":"Literature metadata","dateInSource":"2013-11-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-16352931-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-16352931-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-16352931-goserelin-v1","contentSha256":"e082492bce28f28a3b15307c8ae848b6ea6d6a7ef5d69d7772178d81239248cf"},{"objectId":"story:pubmed-pmid-16392882-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Goserelin: a review of its use in the treatment of early breast cancer in premenopausal and perimenopausal women.","domain":"Literature metadata","dateInSource":"2018-11-13","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-16392882-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-16392882-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-16392882-goserelin-v1","contentSha256":"d8d2d3a46fe9d6f0da083e9fa53332ac3efdfac29b9129589fcf9653ef57ceb8"},{"objectId":"story:pubmed-pmid-16637313-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"[Hysteroresection of submucous myomas after treatment with zoladex].","domain":"Literature metadata","dateInSource":"2013-11-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-16637313-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-16637313-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-16637313-goserelin-v1","contentSha256":"d1eff25ca9b771460a5bdc1ef97225f90281ad385dedf7425bae83242ba37024"},{"objectId":"story:pubmed-pmid-16765589-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93).","domain":"Literature metadata","dateInSource":"2013-11-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-16765589-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-16765589-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-16765589-goserelin-v1","contentSha256":"404d684b5a5926817eba7dcb0868e26364136c7877d04e3b7f184bc600de05ef"},{"objectId":"story:pubmed-pmid-16889194-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"[Using GnRH-agonists (Zoladex) in the treatment of genital endometriosis].","domain":"Literature metadata","dateInSource":"2013-11-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-16889194-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-16889194-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-16889194-goserelin-v1","contentSha256":"2ff486aa3b3bda35bf0655cbcd20677f9f07a666ccfc9fec1875884a608e0a0b"},{"objectId":"story:pubmed-pmid-17257094-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Goserelin acetate in combination with radiotherapy for prostate cancer.","domain":"Literature metadata","dateInSource":"2019-09-17","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-17257094-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-17257094-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-17257094-goserelin-v1","contentSha256":"10321c300109138447ec28d611d7602359bce97240a0df6deaad94bf4c29c821"},{"objectId":"story:pubmed-pmid-20679610-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Phase II trial of anastrozole plus goserelin in the treatment of hormone receptor-positive, metastatic carcinoma of the breast in premenopausal women.","domain":"Literature metadata","dateInSource":"2022-03-31","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-20679610-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-20679610-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-20679610-goserelin-v1","contentSha256":"6ea770d371a7d7e25227432e70c16b16b9be9e2bb94ac3fe78a753adb5b98c00"},{"objectId":"story:pubmed-pmid-21380781-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"A Phase II trial of Zoladex combined with CEF chemotherapy as neoadjuvant therapy in premenopausal women with hormone-responsive, operable breast cancer.","domain":"Literature metadata","dateInSource":"2026-01-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-21380781-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-21380781-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-21380781-goserelin-v1","contentSha256":"15c2cd1ff0761821cfb54e7952d656ac4d35b7a8a74b52e2ef9635b9399ce0fc"},{"objectId":"story:pubmed-pmid-21625929-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer.","domain":"Literature metadata","dateInSource":"2025-04-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-21625929-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-21625929-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-21625929-goserelin-v1","contentSha256":"a09d772ad83380226a6c7078aebe8f92676c472b592e82afef1b2ccf5f40b999"},{"objectId":"story:pubmed-pmid-22265697-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial.","domain":"Literature metadata","dateInSource":"2026-01-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-22265697-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-22265697-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-22265697-goserelin-v1","contentSha256":"720ab3cfa23cb4a0c81b29e6e2257a9f50b9a237222e9c3626cfbbd647c7a0ab"},{"objectId":"story:pubmed-pmid-22674191-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.","domain":"Literature metadata","dateInSource":"2014-11-20","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-22674191-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-22674191-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-22674191-goserelin-v1","contentSha256":"efd4c2256985a3cab87a2f554490ade41c6393b53f94310984d9d7e9ec3bfc3c"},{"objectId":"story:pubmed-pmid-22972694-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer.","domain":"Literature metadata","dateInSource":"2022-03-09","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-22972694-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-22972694-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-22972694-goserelin-v1","contentSha256":"891d4325fffc3d6bdf87b7b8745b93fe54f01c02e13613597e9666555cabf3ca"},{"objectId":"story:pubmed-pmid-23184499-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Preoperative endocrine therapy with goserelin acetate and tamoxifen in hormone receptor-positive premenopausal breast cancer patients.","domain":"Literature metadata","dateInSource":"2026-01-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23184499-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-23184499-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-23184499-goserelin-v1","contentSha256":"8cfb1be24c493d347ac478aa422730af86253728cad758da3b793148f18ad68f"},{"objectId":"story:pubmed-pmid-26131799-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Phase II Trial of Goserelin and Exemestane Combination Therapy in Premenopausal Women With Locally Advanced or Metastatic Breast Cancer.","domain":"Literature metadata","dateInSource":"2026-03-05","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-26131799-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-26131799-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-26131799-goserelin-v1","contentSha256":"1190db10d278acf80803db1d4db2099d45729e6613136f6a404fe4c94578019a"},{"objectId":"story:pubmed-pmid-37114900-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Erythema nodosum caused by goserelin acetate sustained-release: Case report and literature review.","domain":"Literature metadata","dateInSource":"2023-10-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-37114900-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-37114900-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-37114900-goserelin-v1","contentSha256":"6a4d5e1033f7ae524654ab26c5aaa44a9445ae3a309c8393491aca776bce08eb"},{"objectId":"story:pubmed-pmid-38940667-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Apalutamide and Goserelin for Androgen Receptor-Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU.","domain":"Literature metadata","dateInSource":"2025-02-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38940667-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-38940667-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-38940667-goserelin-v1","contentSha256":"7fe81257cbd2910676efaf8f2927ccd9bf55c4c83859f97fee8204753a186b8e"},{"objectId":"story:pubmed-pmid-40268551-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"[Phase Ⅲ, multicenter, randomized comparative study of LY01005 and Zoladex® for patients with premenopausal breast cancer].","domain":"Literature metadata","dateInSource":"2025-05-27","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-40268551-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-40268551-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-40268551-goserelin-v1","contentSha256":"0ac574dd59a946803310b9502a881c2dc30be866cf319d05c817575459474a48"},{"objectId":"story:pubmed-pmid-42226753-goserelin:v1","state":"current","stateChangedAt":"2026-11-15","title":"Roles of Goserelin in Gynecological Disorders.","domain":"Literature metadata","dateInSource":"2026-08-13","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42226753-goserelin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-42226753-goserelin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/goserelin.md#pubmed-pmid-42226753-goserelin-v1","contentSha256":"92b50d190ba9aacd2ac0cad2c9c930495f75ea4a5a3027fcc79bf94f37172e67"}]}
